ALHC (Alignment Healthcare) EBIT: $36 Mil (TTM As of Mar. 2026)


ALHC Alignment Healthcare Inc ALHC
81 GF Score
Price $22.71
GF Value $19.10
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alignment Healthcare EBIT?

Alignment Healthcare ALHC +4.70% 81 EBIT is $36 Mil as of Mar. 2026. GuruFocus rates ALHC with a GF Score™ of 81/100 and a GF Value™ of $19.10 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Alignment Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $36 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alignment Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 was 39.44%. Alignment Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 87.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alignment Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 0.83%.

Alignment Healthcare  (NAS:ALHC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alignment Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=62.012 * ( 1 - 0.22% )/( (163.222 + 150.531)/ 2 )
=61.8755736/156.8765
=39.44 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1065.786 - 507.853 - ( 604.23 - max(0, 556.866 - 951.577+604.23))
=163.222

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1261.608 - 690.469 - ( 726.291 - max(0, 724.757 - 1145.365+726.291))
=150.531

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Alignment Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=62.012/( ( (71.27 + max(-209.519, 0)) + (70.94 + max(-305.683, 0)) )/ 2 )
=62.012/( ( 71.27 + 70.94 )/ 2 )
=62.012/71.105
=87.21 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(253.207 + 0 + 94.14) - (507.853 + 0 + 49.013)
=-209.519

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(277.678 + 0 + 141.396) - (690.469 + 0 + 34.288)
=-305.683

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alignment Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=35.727/4298.600
=0.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alignment Healthcare EBIT Related Terms

Alignment Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Alignment Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alignment Healthcare EBIT Chart

Alignment Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -177.84 -131.01 -126.96 -104.50 14.84

Alignment Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.38 22.83 7.68 -10.28 15.50

ALHC vs CLOV, PGNY, PFHO: EBIT Comparison

For the Healthcare Plans subindustry, Alignment Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alignment Healthcare EV-to-EBIT vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alignment Healthcare's EV-to-EBIT falls into.


ALHC
81GF Score
Alignment Healthcare Inc ALHC
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alignment Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $36 Mil mean?
Alignment Healthcare (ALHC) has a EBIT of $36 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alignment Healthcare.
Is Alignment Healthcare's EBIT too high?
Alignment Healthcare's current EBIT is $36 Mil. Overall, Alignment Healthcare has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alignment Healthcare's EBIT compare to CLOV and PGNY?
Alignment Healthcare's EBIT of $36 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Plans company?
A good EBIT depends on the Healthcare Plans industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alignment Healthcare. Alignment Healthcare's current EBIT is $36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alignment Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Alignment Healthcare (ALHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.10, compared to a current price of $22.71 — trading 18.9% above its estimated fair value. The current EBIT is $36 Mil. Alignment Healthcare's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Alignment Healthcare (ALHC), the current EBIT is $36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alignment Healthcare (ALHC) Overvalued in 2026?

Based on GuruFocus' analysis, Alignment Healthcare stock appears to be overvalued. The current stock price of $22.71 is trading 18.9% above its estimated GF Value™ of $19.10. GuruFocus considers Alignment Healthcare to be Modestly Overvalued.

Key valuation signals for ALHC:

  • EBIT: $36 Mil
  • GF Value™: $19.10 vs. price of $22.71 (18.9% above fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the ALHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alignment Healthcare Business Description

Address 1100 W. Town and Country Road, Suite 1600, Orange, CA, USA, 92868
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
81GF Score

Get the complete analysis for ALHC

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.71
Price
$19.10
GF Value